Leslee J Shaw is an expert in Cardiology at Icahn School of Medicine at Mount Sinai (United States). As of October 2026, ScienceLeadR ranks Leslee J Shaw in the top 1% of experts worldwide for Coronary Disease, Arteriosclerosis and Arterial Occlusive Diseases. Leslee J Shaw has authored 1,172 publications, the most recent in 2026, and is an investigator in 25 clinical trials, 1 of them ongoing. SLR score: 4,570 (community average: 125). How the SLR is computed.

LeadR Profile

Leslee J Shaw Icahn School of Medicine at Mount Sinai United States
4 570 ScienceLeadR Reputation 4570
Network Map

Cardiology

Subspecialties: Medical Imaging - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1998 - 2026

Source: PubMed

Icahn School of Medicine at Mount Sinai

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 1172

Citations

Citations: 90 395 1st author: 129 Last author: 128 Unique author: 27


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Patient-Level Perivascular Adipose Tissue Density Aggregation and Plaque Progression: Plaque-Free vs Plaque-Adjacent Segments.
PMID 42900033 — research design, coronary artery disease, tissues, adipose tissue
JACC Cardiovasc Imaging20260
Bending the Curve: Revealing Population Risk With Quantitative Atherosclerotic Plaque.
PMID 42873176 — plaque, atherosclerotic
JACC Cardiovasc Imaging20260
Rapid progression of coronary atherosclerosis across glycemic status: a serial coronary computed tomography angiography study from the PARADIGM registry.
PMID 42850638 — diabetes mellitus, registries, incidence, tomography, angiography, prediabetic state, atherosclerosis, computed tomography angiography
Cardiovasc Diabetol20260
Improved plaque composition from intensive medical treatment in women with angina and non-obstructive coronary disease.
PMID 42841236 — coronary disease, therapeutics, hydroxymethylglutaryl-coa reductase inhibitors
Cardiovasc Res20260
Sex Differences in Detection of Acute Coronary Syndrome Culprit Lesion Using Conventional and AI-Enhanced Coronary CT Angiography.
PMID 42834459 — constriction, pathologic, acute coronary syndrome, angiography, sex characteristics, sex, artificial intelligence, wounds and injuries, computed tomography angiography, sex differences
Eur Heart J Cardiovasc Imaging20260

Clinical Studies 25

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 4

By phase:

N/A 21
Phase 3 2
Phase 2 1
Phase 4 1

By status:

Completed 18
Active not recruiting 6
Recruiting 1

By type:

Observational 13
Interventional 12

By Monocentric/Multicentric:

monocentric 11
multicentric2to4 2
multicentric5to9 1
multicentricup10 11

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
AI DErived Plaque Quantification CCTA and AI QCPA for Determining Effective CAD Management
NCT06376851 — registries, coronary artery disease, risk assessment, heart, arteries, physicians, artificial intelligence
N/AActive not recruiting2024

LeadR Networks

Main global connection map